Merck ke teesri timahi parinaam Keytruda aur Gardasil ke bal par anumaan se upar, drishtikon badhaya

Merck ne guruwar ko ummeed se zyada teesri timahi kamaai post ki, jo uski cancer dawa Keytruda aur HPV teeke Gardasil ki majboot maang se chali, aur apne warshik rajaswa anumaan ki nichli seema badha di. Report ke baad share bajar khulne se pehle lagbhag 3 pratishat badh gaye.

Teesri timahi ka rajaswa 18.1 arab dollar raha, jo Reuters dwara bataye gaye LSEG aankdon ke anusaar vishleshakon ke 17.3 arab dollar ke ausat anumaan se upar tha. Samayojit kamaai prati share 2.49 dollar rahi, 2.08 dollar ki ummeed se aage. Seeking Alpha ne swatantra roop se wahi parinaam bataya, gair GAAP kamaai prati share 2.49 dollar.

Keytruda aage, naye sanskaran ki madad ke saath

Keytruda ki bikri ek saal pehle ki timahi se 6 pratishat badhkar 8.6 arab dollar ho gayi, vishleshakon ke 8.0 arab dollar ke anumaan se upar, Reuters ne bataya. Kul mein twacha ke neeche diye jaane wale naye sanskaran Keytruda QLEX se 830 million dollar shamil the.

Gardasil CDC ki jaldi khareed par anumaan se aage

Gardasil ki bikri 14 pratishat badhkar lagbhag 2 arab dollar se kuchh kam rahi, 1.8 arab dollar ke anumaan ke mukable, jisme America ke Rog Niyantran aur Roktham Kendron ki jaldi khareed se madad mili. Merck ne yah bhi kaha ki timahi mein company ki vriddhi ka lagbhag 550 million dollar dawaon ki ummeed se pehle ki gayi khareed ke kaaran tha.

Nichli seema par drishtikon badhaya

Merck ne apne warshik rajaswa anumaan ki nichli seema 66.3 arab dollar se badhakar 66.8 arab dollar kar di, jabki pichli uchch seema 67.3 arab dollar aparivartit rakhi. Seeking Alpha ne badhaye gaye drishtikon ko majboot Keytruda aur Winrevair bikri se joda.

Srot

Reuters via Duke FM: Merck ne teesri timahi ke anumaan ko peeche chhoda. Seeking Alpha: Merck ke share badhe. MarketSpeaker: Merck kamaai saraansh.